Severe thrombocytopenia induced by iodinated contrast after coronary angiography: The use of gadolinium contrast and intravascular ultrasound as an alternative to guide percutaneous coronary intervention

Rev Port Cardiol. 2017 Jan;36(1):61.e1-61.e4. doi: 10.1016/j.repc.2016.04.014. Epub 2016 Dec 14.
[Article in English, Portuguese]

Abstract

Acute contrast-induced thrombocytopenia is a rare event with the use of modern low osmolarity iodinated contrast media. The pathophysiological mechanism that causes platelet counts to drop has not been identified, but an immunological mechanism is suspected due to cytotoxicity after previous exposure to contrast. We report the case of a 47-year-old male patient with acute severe thrombocytopenia due to iodinated contrast media exposure. His platelet count after the procedure with the highest amount of contrast was zero, which is the lowest reported platelet count to date. Percutaneous coronary revascularization under both intravascular ultrasound and gadolinium contrast guidance was performed without complications. The most feared complication after the use of gadolinium is nephrogenic systemic fibrosis, especially in patients on hemodialysis.

Keywords: Agentes de contraste; Contrast agents; Ecografia intracoronária; Imagem; Imaging; Intervenção copronária percutânea; Intravascular ultrasound; Percutaneous coronary intervention.

Publication types

  • Case Reports

MeSH terms

  • Contrast Media / adverse effects*
  • Coronary Angiography*
  • Gadolinium
  • Heterocyclic Compounds*
  • Humans
  • Iodine Compounds / adverse effects*
  • Ioxaglic Acid / adverse effects*
  • Male
  • Middle Aged
  • Organometallic Compounds*
  • Percutaneous Coronary Intervention / methods*
  • Severity of Illness Index
  • Surgery, Computer-Assisted*
  • Thrombocytopenia / chemically induced*
  • Ultrasonography, Interventional*

Substances

  • Contrast Media
  • Heterocyclic Compounds
  • Iodine Compounds
  • Organometallic Compounds
  • gadoteridol
  • Gadolinium
  • Ioxaglic Acid